Artwork

Content provided by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Brain stimulation & "psychiatry 3.0" | Nolan Williams

24:52
 
Share
 

Manage episode 364298303 series 3435707
Content provided by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Transcranial magnetic stimulation (TMS) is a technology that uses magnetic fields to stimulate or suppress electrical activity in brain circuits. It's part of a transformation in how psychiatrists are thinking about mental health disorders that today's guest calls psychiatry 3.0.
Nolan Williams has recently pioneered a new form of TMS therapy that has just been approved by the FDA to treat patients with treatment-resistant depression. That actually describes a lot of people with serious depression — somewhere between a third to a half. At some point talk therapy doesn't work, drugs don't work, and for most people, there's not much else to try.
TMS has been used for depression before, but Williams' team has taken a new, more targeted approach. It's called SAINT, which stands for Stanford Accelerated Intelligent Neuromodulation Therapy. Basically, it uses MRI brain imaging to precisely target intensive TMS stimulation to tweak the function of specific circuits in each patient's brain.
Remarkably, after just one week in Williams' SAINT trial, 80% of patients went into full remission. The stories these patients tell about the impact this has had on their lives are incredible.
We talked to Williams, who is a faculty director of the Koret Human Neurosciences Community Laboratory at Wu Tsai Neuro, about what makes this approach unique and what it means for the future of psychiatry.
Additional Reading

Episode Credits
This episode was produced by Webby award-winning producer Michael Osborne, with pro

Send us a text!

Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends. That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience.
Learn more about the Wu Tsai Neurosciences Institute at Stanford and follow us on Twitter, Facebook, and LinkedIn.

  continue reading

38 episodes

Artwork
iconShare
 
Manage episode 364298303 series 3435707
Content provided by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wu Tsai Neurosciences Institute at Stanford University, Nicholas Weiler, Wu Tsai Neurosciences Institute at Stanford University, and Nicholas Weiler or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Transcranial magnetic stimulation (TMS) is a technology that uses magnetic fields to stimulate or suppress electrical activity in brain circuits. It's part of a transformation in how psychiatrists are thinking about mental health disorders that today's guest calls psychiatry 3.0.
Nolan Williams has recently pioneered a new form of TMS therapy that has just been approved by the FDA to treat patients with treatment-resistant depression. That actually describes a lot of people with serious depression — somewhere between a third to a half. At some point talk therapy doesn't work, drugs don't work, and for most people, there's not much else to try.
TMS has been used for depression before, but Williams' team has taken a new, more targeted approach. It's called SAINT, which stands for Stanford Accelerated Intelligent Neuromodulation Therapy. Basically, it uses MRI brain imaging to precisely target intensive TMS stimulation to tweak the function of specific circuits in each patient's brain.
Remarkably, after just one week in Williams' SAINT trial, 80% of patients went into full remission. The stories these patients tell about the impact this has had on their lives are incredible.
We talked to Williams, who is a faculty director of the Koret Human Neurosciences Community Laboratory at Wu Tsai Neuro, about what makes this approach unique and what it means for the future of psychiatry.
Additional Reading

Episode Credits
This episode was produced by Webby award-winning producer Michael Osborne, with pro

Send us a text!

Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends. That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience.
Learn more about the Wu Tsai Neurosciences Institute at Stanford and follow us on Twitter, Facebook, and LinkedIn.

  continue reading

38 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide